Expertise in
6
conditions

Miguel A. Climent

Valencia, VC, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Valencia, VC, ES 

Overview

Miguel Climent practices practicing medicine in Valencia, Spain.

Mr. Climent is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Ileostomy, and Orchiectomy.

He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Valencia, VC, Spain
Other Locations
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Other
Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19)
Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19)
Enrollment Status: Completed
Publish Date: April 01, 2025
A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2024
Intervention Type: Other, Radiation, Drug
Study Drugs: Abiraterone acetate, Docetaxel
Study Phase: Phase 3
Pilot Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study
Pilot Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study
Enrollment Status: Completed
Publish Date: January 09, 2024
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Enrollment Status: Completed
Publish Date: October 18, 2023
Intervention Type: Combination product
Study Drugs: Avelumab 10mg/kg with Carboplatin/Gemcitabine, Carboplatin/Gemcitabine Alone
Study Phase: Phase 2
A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Enrollment Status: Unknown
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drugs: Ipilimumab, Nivolumab, Docetaxel, ADT
Study Phase: Phase 2/Phase 3
Study to Assess Bone Biomarkers for TKI Response in RCC Patients With Bone Metastasis and HRQoL in These Patients as Well as Comparing Whole Body MRI vs. Bone Scintigraphy and vs. CT in the Assessment of Metastatic Lesions
Study to Assess Bone Biomarkers for TKI Response in RCC Patients With Bone Metastasis and HRQoL in These Patients as Well as Comparing Whole Body MRI vs. Bone Scintigraphy and vs. CT in the Assessment of Metastatic Lesions
Enrollment Status: Terminated
Publish Date: April 26, 2018
View 6 Less Clinical Trials

49 Total Publications

Perioperative therapy in muscle-invasive bladder cancer: real-world evidence from the MINOTAURO study.
Perioperative therapy in muscle-invasive bladder cancer: real-world evidence from the MINOTAURO study.
Journal: ESMO real world data and digital oncology
Published: July 28, 2026

Frequently Asked Questions about Miguel A. Climent

Is Miguel A. Climent a top-rated expert for Urothelial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Miguel A. Climent is classified as an Advanced expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Miguel A. Climent participate in research or clinical trials?

Yes. Miguel A. Climent has published 49 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Miguel A. Climent's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Climent's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile